PMA device
POLARx/POLARx FIT Cryoablation Catheters
Boston Scientific Corporation · Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE, Class III) · First FDA decision Aug 8, 2023, newest Jul 5, 2024Atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
4
Naming "POLARx POLARx FIT"
MAUDE reports
2
Brand "POLARx POLARx FIT", since 2015
PubMed studies
0
Mentioning "POLARx POLARx FIT"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing POLARx/POLARx FIT Cryoablation Catheters
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- POLARx/POLARx FIT Cryoablation Catheters, SMARTFREEZE Cryoablation Console, AccessoriesPMA supplement
P220032-S006 · Decided Jul 5, 2024 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
- POLARx/POLARx FIT Cryoablation Catheters, SMARTFREEZE Cryoablation Console, AccessoriesPMA supplement
P220032-S001 · Decided Nov 17, 2023 · 71 days after receipt · Normal 180 Day Track No User Fee
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
P220032 · Decided Aug 8, 2023 · 231 days after receipt
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "POLARx POLARx FIT", any status and sponsor, newest update first.
Boston Scientific CorporationPublic (BSX)
NCT06170606 · 200 participants · Start Jun 28, 2024 · Primary completion May 20, 2026
Device: Boston Scientific Cardiac Cryoablation System · For: Paroxysmal Atrial Fibrillation
Sites: Gilbert, Arizona; Phoenix, Arizona; Tucson, Arizona · 11 sites in all
Erasmus Medical CenterAcademic, hospital or other
NCT05881733 · 20 participants · Start Oct 2, 2023 · Primary completion Apr 29, 2024
Device: POLARx FIT cryoballoon · For: Atrial Fibrillation
Sites: Rotterdam, Netherlands
- Pulsed ElectRic FiEld Versus Cryoballoon for PAFPivotal-lookingCompleted
Universitair Ziekenhuis BrusselAcademic, hospital or other
NCT07100834 · 269 participants · Start Sep 27, 2023 · Primary completion May 30, 2024
Device: Single-Shot Pulsed Field Ablation (FARAPULSE™ Pulsed Field Ablation System); Single-Shot Cryoballoon Devices (Arctic Front Advance PRO, Medtronic Inc., Minneapolis, MN, USA; POLARx and POLARx FIT Balloon Catheter, Marlborough, MA, USA) · For: Atril Fibrillation; Cardiac Arrhythmia; Paroxysmal Atrial Fibrillation (PAF)
Sites: Brussels, Belgium; Zagreb, Croatia; Athens, Greece · 6 sites in all
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "POLARx POLARx FIT", and for the whole product code for context.
This brand
2 reports: 0 malfunction, 2 injury, 0 death
Whole product code OAE
11,261 reports: 5,551 malfunction, 5,370 injury, 334 death
Newest reports for this brand
MW5153462 · Received Apr 1, 2024 · Event dated Mar 5, 2024
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Patient problem as coded: Nerve Damage
MW5151413 · Received Feb 12, 2024 · Event dated Jun 15, 2023
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Patient problem as coded: Laceration(s)
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Boston Scientific POLARx BALLOON CATHETER ST 28MM OUS, Material Number M004CRBS2000.Open, Classified
Z-0297-2025 · Started Oct 10, 2024 · Posted by FDA Nov 12, 2024
Reason given: Boston Scientific is updating the instructions for use of their POLARx and POLARx FIT Cryoablation Balloon Catheters related to Atrio-esophageal Fistula Risk.
Cause as FDA categorized it: Device Design · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Z-0298-2025 · Started Oct 10, 2024 · Posted by FDA Nov 12, 2024
Reason given: Boston Scientific is updating the instructions for use of their POLARx and POLARx FIT Cryoablation Balloon Catheters related to Atrio-esophageal Fistula Risk.
Cause as FDA categorized it: Device Design · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Z-0299-2025 · Started Oct 10, 2024 · Posted by FDA Nov 12, 2024
Reason given: Boston Scientific is updating the instructions for use of their POLARx and POLARx FIT Cryoablation Balloon Catheters related to Atrio-esophageal Fistula Risk.
Cause as FDA categorized it: Device Design · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
4 more recall records with a free account
Published research
The most relevant PubMed records for "POLARx POLARx FIT"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OAE.
- Arctic Front Advance and Arctic Front Advance ProMedtronic Cryocath, LP · PMA 2024
- Arctic Front Cardiac Cryoablation Catheter SystemMedtronic Cryocath, LP · PMA 2024
- TactiCath Contact Force Ablation Catheter, Sensor EnabledSt Jude Medical · PMA 2023
- HeartLight Catheter, HeartLight X3 Console V2Cardiofocus, Inc. · PMA 2023
- TactiFlex Sensor Enabled Ablation CatheterAbbott Medical · PMA 2026
- DiamondTemp Ablation SystemMedtronic, Inc. · PMA 2025
- TactiCath Quartz Contact Force Ablation CatheterSt Jude Medical · PMA 2021
- QDOT MICRO SystemBiosense Webster, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.